+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Liver Disease Diagnostics Market Research Report by Diagnosis Technique, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 224 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5533043
UP TO OFF until Dec 31st 2022
The Global Liver Disease Diagnostics Market size was estimated at USD 158.91 million in 2021, USD 178.26 million in 2022, and is projected to grow at a CAGR of 12.43% to reach USD 321.04 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Liver Disease Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Diagnosis Technique, the market was studied across Biopsy, Endoscopy, Imaging, and Laboratory tests.
  • Based on End-user, the market was studied across Hospitals and Laboratories.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Liver Disease Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Liver Disease Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Liver Disease Diagnostics Market, including Abbott Laboratories, AstraZeneca PLC, Bayer AG, bioMérieux SA, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Gilead Science Inc., GlaxoSmithKline plc, Horiba, Ltd., Laboratory Corporation of America Holdings, Merck & Co. Inc, Mylan N.V., Novartis AG, Pfizer, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Sanofi S.A, SciCann Therapeutics, Siemens Healthineers AG, and Thermo Fisher Scientific.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Liver Disease Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Liver Disease Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Liver Disease Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Liver Disease Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Liver Disease Diagnostics Market?
6. What is the market share of the leading vendors in the Global Liver Disease Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Liver Disease Diagnostics Market?
Frequently Asked Questions about the Global Liver Disease Diagnostics Market

What is the estimated value of the Global Liver Disease Diagnostics Market?

The Global Liver Disease Diagnostics Market was estimated to be valued at $158.91 Million in 2021.

What is the growth rate of the Global Liver Disease Diagnostics Market?

The growth rate of the Global Liver Disease Diagnostics Market is 12.4%, with an estimated value of $321.04 Million by 2027.

What is the forecasted size of the Global Liver Disease Diagnostics Market?

The Global Liver Disease Diagnostics Market is estimated to be worth $321.04 Million by 2027.

Who are the key companies in the Global Liver Disease Diagnostics Market?

Key companies in the Global Liver Disease Diagnostics Market include Abbott Laboratories, AstraZeneca PLC, Bayer AG, bioMérieux SA, Boston Scientific Corporation, F. Hoffmann, La Roche Ltd, Fujifilm Holdings Corporation and GlaxoSmithKline plc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of acute and chronic liver diseases
5.1.1.2. Changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets
5.1.1.3. Development of the government and non-government awareness programs
5.1.2. Restraints
5.1.2.1. High cost of imaging test and lack of skilled professional in low and middle-income countries
5.1.3. Opportunities
5.1.3.1. Availability of biosimilar and generic drugs
5.1.3.2. Rising R&D investments for developing novel therapies
5.1.4. Challenges
5.1.4.1. Side effect incorporated with medication
5.2. Cumulative Impact of COVID-19
6. Liver Disease Diagnostics Market, by Diagnosis Technique
6.1. Introduction
6.2. Biopsy
6.3. Endoscopy
6.4. Imaging
6.5. Laboratory tests
7. Liver Disease Diagnostics Market, by End-user
7.1. Introduction
7.2. Hospitals
7.3. Laboratories
8. Americas Liver Disease Diagnostics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Liver Disease Diagnostics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Liver Disease Diagnostics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. AstraZeneca PLC
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Bayer AG
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. bioMérieux SA
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Boston Scientific Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. F. Hoffmann-La Roche Ltd
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Fujifilm Holdings Corporation
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Gilead Science Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. GlaxoSmithKline plc
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Horiba, Ltd.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Laboratory Corporation of America Holdings
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Merck & Co. Inc
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Mylan N.V.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Novartis AG
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Pfizer, Inc.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Qiagen N.V.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Quest Diagnostics Incorporated
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Randox Laboratories Ltd.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Sanofi S.A
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. SciCann Therapeutics
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Siemens Healthineers AG
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Thermo Fisher Scientific
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 11. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSIS TECHNIQUE, 2027
FIGURE 14. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 19. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 21. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 23. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 24. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 25. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 26. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 27. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 33. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 35. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 37. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 38. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 39. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 55. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 77. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 78. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 28. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 29. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 30. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 32. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 33. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 35. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 36. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 38. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 39. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 41. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 45. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 50. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 52. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 53. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 55. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 56. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 58. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 59. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 61. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 62. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 64. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 65. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 67. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 68. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 69. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 70. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 71. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 73. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 74. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 75. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 76. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 77. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 78. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 79. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 80. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 82. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 83. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 85. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 90. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 91. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 92. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 93. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 94. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 95. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 96. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 97. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 98. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 99. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 101. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 102. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 104. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 105. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 106. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 107. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 108. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 110. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 111. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 113. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 114. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 116. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 117. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 119. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 120. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 122. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 123. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 125. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 126. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 128. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 129. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 131. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 132. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 134. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 135. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 137. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 138. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 140. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 141. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 143. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 144. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 146. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 150. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 151. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 152. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 153. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 154. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 155. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 156. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 157. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 158. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET MERGER & ACQUISITION
TABLE 159. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 160. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 161. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET INVESTMENT & FUNDING
TABLE 162. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 163. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • bioMérieux SA
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • Gilead Science Inc.
  • GlaxoSmithKline plc
  • Horiba, Ltd.
  • Laboratory Corporation of America Holdings
  • Merck & Co. Inc
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Sanofi S.A
  • SciCann Therapeutics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...